From Noida lab, a next gen cancer therapy that keeps it from coming back | Health and Wellness News
With cancer incidence on the rise — and the cost of newer therapies keeping them out of reach of most — there has been a race to develop CAR-T cell therapies for Indian patients. Among researchers dedicated to lengthening the life span of survivors are those sitting in an unassuming building in the heart of Noida, who have been working tirelessly through the pandemic to develop therapies that are not just cost-effective but also innovative. CAR T cell therapies — or chimeric antigen receptor T cell therapies — collect a patient’s own immune T cells, re-engineer them in the laboratory, multiply them and then infuse them back into the patient. These engineered T cells can then identify the cancer cells, attach themselves to them, ultimately destroying them. The latest innovation is about making them more persistent against a relapse. Cellogen Therapeutics is set to begin human trials soon for its novel CAR-T therapy at Christian Medical College-Vellore. It can not only fight a patient’s current cancer but also create a memory in the body’s immune …








